Post-injury treatment with 7,8dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling
Year:
2014
Tissue Type:
Cell Type:
Organ Type:
System Type:
12 min read
Get In Touch
At Flexcell® International Corporation, we understand that our commitment to the highest quality products and customer service are core to our business. Reach out to us today to see how we can apply those principals to your business.